CLINICAL_TRIALS
trial_result
· 2012-10-05
Clinical Trial Update: Flavopiridol to Treat Relapsed Mantle Cell Lymphoma or Diffuse Large B-Cell Lymphoma [Phase 1, Phase 2]
Summary
A completed Phase 1/2 trial evaluating flavopiridol for relapsed mantle cell lymphoma or diffuse large B-cell lymphoma has results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Cancer Institute (NCI) | Conditions: Lymphoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2012-10-05